The telehealth weight loss market moved fast in early 2026. Novo Nordisk’s March settlement pushed several major platforms away from compounded semaglutide and toward branded drugs at much higher price points. Lilly quietly launched oral orforglipron through LillyDirect around April at roughly $149 a month. And the FDA sent warning letters to more than 30 compounding pharmacies and telehealth firms in the same window. So if you were comparing options from even a year ago, that list is already outdated.
Before I get into the nine programs, let me explain how I’d think through this choice.
How to Actually Decide
Budget first. Branded Wegovy runs around $299/month through Hims & Hers without insurance. Compounded options start as low as $99. That gap matters enormously over a year.
Pharmacy transparency second. The FDA enforcement wave means you want a named, verifiable 503A-registered compounding pharmacy, not just “a licensed facility.” Some brands publish this. Many do not.
Monitoring and access third. Some programs give you a physician review in 24 hours and ship overnight. Others have multi-week onboarding queues. If you’re traveling or in a rural state, 50-state shipping with overnight delivery is a real advantage.
Purity documentation fourth. A handful of brands publish batch-level lab results. Most do not. That detail matters if you want to verify what’s in the vial.
With those four filters in mind, here’s where each program lands.
The 9 Programs
1. HealthRX
This one wins on the price-and-access combination more clearly than anything else I found. Compounded semaglutide starts at $99 a month, tirzepatide at $149. Both come from Manifest Pharmacy in Greer, South Carolina, a 503A/USP-797 operation with lot-by-lot tracking from compounding bench to your door. The pharmacy holds LegitScript certification (cert 50087439), which is publicly verifiable. A board-certified physician reviews your intake form within roughly 24 hours, and the medication ships overnight to all 50 states at no extra cost. Upfront pricing, no contracts, no hidden fees.
The efficacy numbers HealthRX cites come from published clinical trials: the SURMOUNT-1 trial showed about 21% body weight reduction with tirzepatide over 72 weeks; STEP 1 showed roughly 15% with semaglutide over 68 weeks. These are compounded medications, not FDA-approved branded drugs, so that distinction matters.
For men who want a fast, affordable, verifiable cash-pay option with named pharmacy sourcing, this is the strongest starting point.
2. FormBlends
If purity documentation is your deciding factor, FormBlends earns serious attention. The brand publishes per-vial lab results for its compounded GLP-1 medications, including HPLC purity percentages, mass spec identity confirmation, and endotoxin sterility data with named numbers. That level of transparency is genuinely rare in this space.
Dispensed through an FDA-registered 503A compounding pharmacy with physician oversight, FormBlends carries compounded semaglutide around $299 and tirzepatide around $349. It ships to 47 states. The price is higher than HealthRX’s entry point, which is why it sits at number two rather than number one here. But FormBlends also runs a broader peptide catalog covering recovery, cognitive support, and longevity compounds under the same clinical model. If you want GLP-1 therapy plus access to peptides like BPC-157 or other compounds from a single provider with documented purity testing, this is the better fit.
3. Mochi Health
Mochi is worth a look if you want obesity-medicine specialists rather than general telehealth physicians. Monthly cash-pay pricing lands at roughly $99 for compounded semaglutide and around $199 for tirzepatide. The monitoring is more structured than lighter-touch platforms, which some men prefer and others find excessive.
4. Henry Meds
Fast. Henry Meds focuses on speed: 24 to 72-hour shipping on compounded medications, cash-pay pricing in the $179 to $249 range for the first month. Lighter on ongoing monitoring than Mochi. Good fit for men who’ve already done the research and just want quick access at a reasonable cost.
5. Ro Body
Ro’s prior-authorization team handles insurance paperwork for branded medications, which is genuinely useful if you have coverage. Membership starts around $39 for the first month, then $74 to $149, with medications billed separately. Takes insurance for branded options.
6. PlushCare
PlushCare runs a low membership fee, around $19.99 a month, and offers same-day telehealth visits. It focuses on branded medications and works with insurance. A straightforward option if you want speed and your insurer covers GLP-1 drugs.
7. Hims & Hers
After the March 2026 Novo settlement, Hims & Hers shifted to branded medications. Injectable Wegovy is priced at approximately $299 a month, oral semaglutide at approximately $249, and Zepbound at approximately $399. With insurance and savings cards, some men get to near zero cost. Without insurance, it’s among the pricier options on this list.
8. Found
Found charges roughly $99 a month for platform access plus medications, and includes coaching. It’s a decent middle-ground option for men who want some behavioral support built in without the heavier commitment of a program like Calibrate.
9. Form Health
Premium tier. Form Health pairs an MD with a registered dietitian at around $299 a month plus labs and medication costs. This is the most intensive option on the list. Probably more than most men need, but right for someone who wants clinical-grade accountability and doesn’t mind paying for it.
Common Questions
Does it matter whether you get compounded semaglutide or branded Wegovy if the active ingredient is the same?
Yes, it matters. Compounded semaglutide is not FDA-approved as a finished drug product, even when the active molecule matches. Branded Wegovy carries full FDA approval for the formulation, device, and manufacturing process. Compounded versions can vary by pharmacy. That difference is real, even if the clinical trials used the same molecule.
Which of these programs actually names its compounding pharmacy upfront, and why should men care?
HealthRX publicly names Manifest Pharmacy in Greer, South Carolina, with a verifiable LegitScript certification number. FormBlends also discloses pharmacy sourcing. Most other platforms on this list do not name their pharmacy publicly. After the FDA’s 2026 warning letter campaign, that transparency gap is a meaningful quality signal, not a minor detail.
If a man has cardiovascular risk factors, does any program here offer more clinical oversight than the others?
Form Health comes closest, pairing an MD with a registered dietitian and including labs. Mochi uses obesity-medicine specialists rather than general practitioners. Both are more appropriate for men with complex health histories than faster-access options like Henry Meds or PlushCare, which prioritize speed over depth of clinical review.
How does Hims & Hers pricing compare now that it moved away from compounded medications after the March 2026 settlement?
Substantially higher. Hims & Hers now lists injectable Wegovy at roughly $299 a month, oral semaglutide at $249, and Zepbound at $399, all without insurance. A year ago, compounded options through the same platform were considerably cheaper. Insurance or manufacturer savings cards change that math significantly for some men.
Can men in all 50 states actually access every program on this list?
No. FormBlends ships to 47 states, not all 50. HealthRX ships overnight to all 50 states. Other programs vary by state licensing and pharmacy logistics. If you’re in a less-served state or travel frequently, confirming coverage before starting an onboarding process saves time.
A Note Before You Decide
None of these programs are identical in what they deliver, and compounded GLP-1 medications are not FDA-approved drugs regardless of where they come from. Talking to your own doctor before starting any of these is a reasonable step, particularly if you have cardiovascular conditions, a history of thyroid cancer, or are on other medications that could interact. This article reflects publicly available pricing and facts as of mid-2026 and does not substitute for medical advice.
Sources
- FDA.gov: 503A compounding pharmacy regulations and 2026 warning letter activity
- LegitScript public certification database
- SURMOUNT-1 trial: Jastreboff et al., *New England Journal of Medicine*, 2022
- STEP 1 trial: Wilding et al., *New England Journal of Medicine*, 2021
- Novo Nordisk March 2026 settlement: publicly reported across Reuters, STAT News, and FDA announcements
- LillyDirect orforglipron launch pricing: Eli Lilly press materials, April 2026
- Individual platform pricing: brand websites accessed 2026
